Vyome Holdings Inc. Common Stock (HIND)

About HIND

Vyome Holdings, Inc., a clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States. It operates through Pharmaceutical and Biotechnology segments. The company's lead product candidate VT-1953, a dual DNA Gyrase/Topoisomerase inhibitor and immunomodulator in a topical gel formulation that is in phase 2 clinical stage for the treat…

Sector

Health Care

Industry

Medical/Dental Instruments

Employees

9

Website

www.vyometx.com

Fundamentals

1-day range

$2.12$2.23

Market cap

$15.20M

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-1.56

Dividend yield

—

Beta

—

Avg. volume

17.2K

Forecasts

2 analyst ratings

Vyome Holdings Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• HIND

  Vyome Holdings Inc. Common Stock

  $2.2

  ▼ 0.23%
  Market cap $15.20MP/E —
  $1.75$12.87
• OSRH

  OSR Health Inc. Common Stock

  $0.26

  ▲ 52.94%
  Market cap $15.67MP/E 10.53
  $0.075$0.9078
• SINT

  SiNtx Technologies Inc. Common Stock

  $1.51

  ▼ 1.31%
  Market cap $11.25MP/E —
  $1.4$6.78
• RVP

  Retractable Technologies Inc. Common Stock

  $0.73

  ▲ 2.82%
  Market cap $19.76MP/E —
  $0.6017$1.14
• QNRX

  Quoin Pharmaceuticals Ltd. American Depositary Shares

  $6.13

  ▲ 18.91%
  Market cap $8.94MP/E —
  $3.25$41.8
• CODX

  Co-Diagnostics Inc. Common Stock

  $1.2

  ▼ 4.76%
  Market cap $7.81MP/E —
  $0.9396$46.5
• NVNO

  enVVeno Medical Corporation Common Stock

  $10.67

  ▼ 5.12%
  Market cap $7.31MP/E —
  $8.67$36.05

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• 12 Health Care Stocks Moving In Friday's After-Market Session
  Benzinga · 8/7/2026

Institutional Ownership

March 31, 2026

Total shares held

79.8K

Total value held

$172.1K

Institutional holders

8